NCT03080948View on ClinicalTrials.gov

Risk Stratification Among Individuals Who Have Many Moles on Their Skin

Active, not recruitingOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

March 9, 2017

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
High-Risk Nevus Phenotype
Interventions
BEHAVIORAL

survey

Research assessments as part of this protocol will be scheduled during routine clinic visits

OTHER

Saliva samples

Germline DNA analysis

Trial Locations (4)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester, Harrison

11788

Memorial Sloan Kettering Cancer Center Hauppauge, Hauppauge

07920

Memorial Sloan Kettering Basking Ridge, Basking Ridge

All Listed Sponsors
collaborator

Princess Alexandra Hospital, Brisbane, Australia

OTHER

collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03080948 - Risk Stratification Among Individuals Who Have Many Moles on Their Skin | Biotech Hunter | Biotech Hunter